Core Viewpoint - Red Robin (RRGB) has shown an 8.1% increase in stock price over the past four weeks, with a mean price target of $9.38 indicating a potential upside of 49.1% from the current price of $6.29 [1] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $3.94, where the lowest estimate is $3.50 (44.4% decline) and the highest is $12.00 (90.8% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about RRGB's earnings prospects, as indicated by a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 14.5%, with one estimate moving higher and no negative revisions [12] - RRGB holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Targets - While the consensus price target may not be a reliable indicator of the stock's potential gain, it does provide a directional guide for price movement [14]

Company Overview - Vir Biotechnology, Inc. (VIR) shares increased by 11.9% to close at $5.93, with trading volume significantly higher than usual, contrasting with a 2.2% loss over the past four weeks [1][2] Pipeline and Development - The rise in stock price is linked to positive investor sentiment regarding tobevibart, Vir Biotechnology's late-stage pipeline candidate, which is in a phase III ECLIPSE 1 study for chronic hepatitis delta (CHD) treatment [2] - The company is preparing to start a phase III ECLIPSE 2 study to evaluate the efficacy and safety of switching to tobevibart and elebsiran for CHD patients not achieving viral suppression with bulevirtide [2] Financial Expectations - The upcoming quarterly report is expected to show a loss of $0.74 per share, reflecting a year-over-year increase of 27.5%, while revenues are projected at $7.05 million, up 128.8% from the previous year [3] - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Vir Biotechnology operates within the Zacks Medical - Biomedical and Genetics industry, which includes other companies like Opus Genetics, Inc. (IRD), that also has a Zacks Rank of 2 (Buy) [4][5]

Company Overview - TopBuild shares increased by 6.1% to close at $378.8, supported by strong trading volume, and have gained 15.3% over the past four weeks [1][2] - The company announced an $810 million cash acquisition of Progressive Roofing, which is expected to enhance its position in the commercial roofing segment [2] Financial Performance - TopBuild is projected to report quarterly earnings of $5.10 per share, reflecting a year-over-year decline of 5.9%, with expected revenues of $1.29 billion, down 5.5% from the previous year [3] - The consensus EPS estimate for TopBuild has remained unchanged over the last 30 days, indicating stability in earnings expectations [4] Industry Context - TopBuild is part of the Zacks Building Products - Miscellaneous industry, which includes other companies like Janus International Group, Inc. [5] - Janus International Group's consensus EPS estimate has also remained unchanged at $0.15, representing a year-over-year decline of 28.6% [6]

Core Insights - Analysts project State Street Corporation (STT) will report quarterly earnings of $2.36 per share, a 9.8% increase year over year, with revenues expected to reach $3.37 billion, up 5.7% from the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has been revised 4.5% higher in the last 30 days, indicating a collective reevaluation by analysts [2] - Revisions to earnings projections are critical for predicting investor behavior and are strongly linked to short-term stock price performance [3] Key Metrics Projections - Analysts expect the 'Basel III Advanced Approaches - Tier 1 Leverage Ratio' to reach 5.4%, up from 5.3% in the same quarter last year [5] - The 'Average balance - Total interest-earning assets' is projected at $291.11 billion, compared to $261.74 billion a year ago [5] - The 'Basel III Standardized Approach - Tier 1 capital ratio' is expected to be 13.6%, an increase from 13.3% year over year [6] - 'Assets under Management (AUM)' is forecasted to be $4800.97 billion, up from $4415.00 billion in the same quarter last year [6] - The 'Basel III Standardized Approach - Total capital ratio' is estimated at 14.7%, down from 15.0% a year ago [7] - 'Assets under Custody and/or Administration (AUC/A)' is projected at $41922.09 billion, compared to $44312.00 billion last year [7] Revenue Projections - 'Net Interest Income' is estimated at $734.82 million, slightly down from $735.00 million in the same quarter last year [8] - 'Total fee revenue' is projected to reach $2.64 billion, up from $2.46 billion a year ago [8] - 'Net Interest Income - fully taxable-equivalent basis' is expected to be $733.49 million, compared to $736.00 million last year [9] - 'Software and processing fees' are estimated at $231.30 million, up from $214.00 million in the same quarter last year [9] - 'Other fee revenue' is projected at $58.70 million, compared to $48.00 million a year ago [10] - 'Management fees' are expected to reach $558.82 million, up from $511.00 million last year [10] Stock Performance - Shares of State Street have increased by 12.4% in the past month, outperforming the Zacks S&P 500 composite, which rose by 4.4% [10]

Core Viewpoint - BlackRock is expected to report quarterly earnings of $10.77 per share, a 4% increase year-over-year, with revenues projected at $5.38 billion, reflecting a 12% year-over-year growth [1]. Earnings Estimates - Wall Street analysts have revised the consensus EPS estimate upward by 1.7% over the last 30 days, indicating a collective reassessment of forecasts [2]. - Revisions to earnings estimates are significant indicators for predicting investor actions regarding the stock [3]. Revenue Projections - Analysts project 'Revenue- Technology services revenue' at $493.72 million, a year-over-year increase of 25% [5]. - 'Revenue- Advisory and other revenue' is expected to reach $59.44 million, reflecting a 12.1% year-over-year increase [5]. - 'Revenue- Investment advisory performance fees' is forecasted at $156.55 million, indicating a year-over-year decline of 4.6% [5]. - The consensus for 'Revenue- Distribution fees' is $323.27 million, a 1.7% year-over-year increase [6]. - 'Revenue- Total investment advisory, administration fees and securities lending revenue' is expected to be $4.36 billion, showing a 12.6% year-over-year growth [6]. Assets Under Management - 'Assets under management - Cash management' is projected at $771.17 billion, down from $778.04 billion year-over-year [7]. - 'Total Assets Under Management' is expected to reach $11,679.24 billion, up from $10,645.72 billion in the same quarter last year [7]. - 'Assets under management - Long-term' is forecasted at $10,762.03 billion, compared to $9,867.68 billion in the same quarter last year [8]. - 'Assets under management - ETFs' is estimated at $4,295.42 billion, up from $3,855.77 billion year-over-year [9]. Net Inflows - 'Net inflows - Product Type - Cash management' is projected to be $66.79 billion, compared to $30.20 billion year-over-year [8]. - 'Net inflows' are expected to reach $124.01 billion, up from $81.57 billion in the same quarter last year [9]. - 'Net inflows - Client Type - ETFs' is estimated at $57.88 billion, down from $83.14 billion in the same quarter last year [10]. Stock Performance - BlackRock shares have increased by 9.6% over the past month, outperforming the Zacks S&P 500 composite's 4.4% increase [11].

Core Viewpoint - JB Hunt (JBHT) is expected to report quarterly earnings of $1.34 per share, a 1.5% increase year-over-year, with revenues forecasted at $2.96 billion, reflecting a 1.1% year-over-year increase [1]. Earnings Estimates - The consensus EPS estimate has been revised downward by 0.7% over the past 30 days, indicating a collective reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts project 'Revenue- Truckload' at $163.94 million, indicating a year-over-year decrease of 2.5% [4]. - 'Revenue- Dedicated' is expected to reach $849.27 million, reflecting a slight decrease of 0.2% from the previous year [5]. - 'Revenue- Final Mile Services' is estimated at $219.08 million, showing a year-over-year decline of 6.9% [5]. - 'Revenue- Integrated Capacity Solutions' is forecasted to be $272.18 million, indicating a 0.7% increase from the prior year [5]. Key Metrics - The consensus for 'Dedicated - Average trucks during the period' is 12,624, down from 13,142 year-over-year [6]. - 'Integrated Capacity Solutions - Revenue per load' is projected at $1,949.26, compared to $1,860.00 last year [6]. - 'Intermodal - Revenue per load' is expected to be $2,797.39, down from $2,829.00 year-over-year [6]. - 'Intermodal - Trailing equipment (end of period)' is estimated at 125,792, up from 121,169 last year [7]. - 'Final Mile Services - Average trucks during the period' is projected at 1,347, down from 1,374 year-over-year [7]. Load Estimates - 'Integrated Capacity Solutions - Loads' is expected to be 140,866, down from 145,362 last year [8]. - 'Intermodal - Loads' is forecasted at 523,353, an increase from 497,446 in the same quarter last year [8]. - 'Truckload - Loads' is projected to reach 94,663, up from 92,628 year-over-year [8]. Stock Performance - Over the past month, JB Hunt shares have returned +8.4%, outperforming the Zacks S&P 500 composite's +4.4% change [9]. - JBHT holds a Zacks Rank 4 (Sell), indicating a likely underperformance compared to the overall market in the upcoming period [9].

In its upcoming report, The Bank of New York Mellon Corporation (BK) is predicted by Wall Street analysts to post quarterly earnings of $1.74 per share, reflecting an increase of 15.2% compared to the same period last year. Revenues are forecasted to be $4.86 billion, representing a year-over-year increase of 5.6%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.2% to its current level. This demonstrates the covering analysts' collective reassessment of their i ...

Analysts on Wall Street project that Fulton Financial (FULT) will announce quarterly earnings of $0.43 per share in its forthcoming report, representing a decline of 8.5% year over year. Revenues are projected to reach $323.4 million, declining 4.7% from the same quarter last year.The consensus EPS estimate for the quarter has undergone a downward revision of 1.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estim ...

Core Viewpoint - Analysts project Hancock Whitney (HWC) will report quarterly earnings of $1.34 per share, a 2.3% increase year over year, with revenues expected to reach $371.26 million, up 3.2% from the same quarter last year [1]. Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions to the stock, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock price performance [2]. Key Metrics Projections - Analysts expect the 'Net interest margin (TE)' to be 3.5%, up from 3.4% in the same quarter last year [4]. - The 'Efficiency Ratio' is projected at 55.9%, compared to 56.2% a year ago [4]. - 'Average Balance - Total interest earning assets' is expected to reach $32.05 billion, down from $32.54 billion in the same quarter last year [5]. - 'Total nonperforming loans' are estimated at $106.46 million, up from $86.25 million a year ago [5]. - 'Total nonperforming assets' are projected to be $138.95 million, compared to $88.37 million in the same quarter last year [6]. - 'Total Noninterest Income' is forecasted at $96.84 million, up from $89.17 million a year ago [6]. - 'Net interest income (TE)' is expected to reach $278.55 million, compared to $273.26 million in the same quarter last year [7]. - 'Bank card and ATM fees' are estimated at $21.14 million, down from $21.83 million a year ago [8]. - 'Investment and annuity fees and insurance commissions' are projected at $10.47 million, up from $9.79 million last year [9]. - 'Other income' is expected to be $15.64 million, compared to $13.26 million a year ago [9]. Stock Performance - Hancock Whitney shares have increased by 11.6% in the past month, outperforming the Zacks S&P 500 composite's 4.4% increase, with a Zacks Rank 2 (Buy) indicating expected outperformance in the near term [10].

Core Viewpoint - Analysts project that JPMorgan Chase & Co. will report quarterly earnings of $4.51 per share, a 2.5% increase year over year, with revenues expected to decline by 12.7% to $43.81 billion [1] Earnings Estimates - The consensus EPS estimate has been revised upward by 1.5% in the past 30 days, indicating a reassessment by covering analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts forecast 'Consumer & Community Banking - Revenue By Line of Business - Card Services & Auto' to reach $6.76 billion, reflecting a 12.6% year-over-year increase [5] - 'Consumer & Community Banking - Revenue By Line of Business - Home Lending' is projected at $1.28 billion, indicating a 2.8% decline from the previous year [5] - 'Total Net Revenue - Line of Business Net Revenue - Asset & Wealth Management' is expected to be $6.09 billion, a 15.9% increase year over year [6] - 'Total Net Revenue - Line of Business Net Revenue - Consumer & Community Banking' is estimated at $18.55 billion, showing a 4.8% increase from the prior year [6] Key Metrics - 'Consumer & Community Banking - Revenue By Line of Business - Banking & Wealth Management' is projected to be $10.50 billion, a 1.2% increase year over year [7] - Analysts expect 'Book value per share' to be $122.72, up from $111.29 in the same quarter last year [7] - 'Total Interest Earning Assets - Average Balance' is anticipated to reach $3648.52 billion, compared to $3509.73 billion in the same quarter last year [8] - 'Total Non-Performing Assets' is projected at $9.73 billion, up from $8.42 billion in the previous year [8] Capital Ratios - The 'Tier 1 leverage ratio' is expected to be 7.1%, slightly down from 7.2% reported in the same quarter last year [9] - 'Total Non-Performing Loans' is estimated at $9.14 billion, compared to $7.79 billion in the same quarter last year [9] - The average prediction for 'Tier 1 Capital Ratio' is 16.3%, down from 16.7% in the previous year [10] - The estimated 'Total Capital Ratio' is 17.7%, compared to 18.5% reported in the same quarter last year [10] Stock Performance - JPMorgan Chase & Co. shares have increased by 5.6% in the past month, outperforming the Zacks S&P 500 composite's 4.4% increase [11]